University of Pittsburgh researchers have developed MyVoice, a novel web-based decision aid designed to assist women with rheumatic diseases in making informed family planning decisions. This innovative tool addresses the unique sexual and reproductive health needs of this patient population. Rheumatic diseases significantly increase the risks associated with reproductive health, yet there is often a lack of discussion between patients and healthcare providers on these topics. MyVoice aims to bridge this gap by enhancing patient-provider communication and shared decision-making, thereby improving reproductive health outcomes.
Description
MyVoiceis a patient-facing decision aid designed to be used by reproductive-aged women with rheumatic diseases. It enables patients to explore information specific to their rheumatic condition and reproductive goals, guiding them through topics such as conception, fertility, pregnancy planning, medication safety during pregnancy, contraception, and parenting. The tool is accessible via mobile devices and tablets, ensuring easy integration into clinical settings. By using MyVoice, patients generate a summary page highlighting their goals, questions, and needs, which can be shared with their rheumatologist to facilitate meaningful conversations and personalized care. sensors that are stable, easy to manufacture, and capable of generating significant voltages.
Applications
- Patient-provider communication
- Reproductive health
- Rheumatic diseases
Advantages
MyVoice stands out as the first decision aid specifically tailored for women with rheumatic diseases, filling a critical gap in patient care. This innovative tool offers customizable content, allowing patients to select topics most relevant to their needs, ensuring a personalized and targeted experience. By facilitating improved communication between patients and providers, MyVoice aims to significantly reduce the risks of adverse reproductive outcomes associated with rheumatic diseases. Additionally, its user-friendly design and mobile accessibility make it easy to integrate into clinical settings, enhancing its practicality and effectiveness in real-world applications.
Invention Readiness
MyVoice is currently at the prototype stage, with development supported by the Pittsburgh Autoimmunity Center of Excellence in Rheumatology (PACER). The tool has been tested for usability and effectiveness in enhancing patient-provider communication and is ready for broader implementation.
IP Status
Software
